Company profile

Suven Life Sciences

SUVEN · NSE (Also listed on BSE (530239)) · India

Public Market Listing

SUVENNSE

NSE primary exchange listing

Live quotes, historical charts, and market capitalization for Suven Life Sciences are available on Yahoo Finance.

View quote & market cap on Yahoo Finance ↗

External market data link · No third-party exchange redistribution

Assets

(2 total)
2Total Assets
0Approved
1Phase 3 / Filed
1Phase 1–2 / Early
2Diseases
Quick filter:
Showing 2 of 2 assets
Target & Modality
Masupirdine
Phase 3
Serotonin 5-HT6 receptorSmall molecule
Alzheimer's Disease
Ropanicant
Phase 2
Alpha4beta2 nicotinic acetylcholine receptorSmall molecule
Major Depressive Disorder

Upcoming events

Research

Unlock the company readout calendar

Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.

Financial reports

Research

Unlock sourced financial history

Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.

Educational data tool. Figures are sourced from company filings and press releases: see each row's filing link. Share price is delayed (~15min) and refreshed periodically, not a real-time feed.